These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6172019

  • 1. Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders.
    Gabay S.
    Adv Exp Med Biol; 1981; 133():585-601. PubMed ID: 6172019
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evidence for the role of brain biogenic amines in depressed motor activity seen in chemically thyroidectomized rats.
    Rastogi RB, Lapierre Y, Singhal RL.
    J Neurochem; 1976 Mar; 26(3):443-9. PubMed ID: 4580
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG, Bustos G, Redmond DE, Roth RH.
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
    Agarwal RA, Rastogi RB, Singhal RL.
    Neuroendocrinology; 1977 Apr; 23(4):236-47. PubMed ID: 409963
    [No Abstract] [Full Text] [Related]

  • 8. The serotonergic system in the brain and its possible functional connections with other aminergic systems.
    Samanin R, Garattini S.
    Life Sci; 1975 Oct 15; 17(8):1201-9. PubMed ID: 574
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover.
    Hall LM, Anderson GM, Cohen DJ.
    Life Sci; 1995 Oct 15; 57(8):791-801. PubMed ID: 7543647
    [Abstract] [Full Text] [Related]

  • 11. Rotational behavior produced by unilateral ventral noradrenergic bundle lesions: evidence for a noradrenergic-dopaminergic interaction in the brain.
    Płaźnik A, Puciłowski O, Kostowski W, Bidziński A, Hauptmann M.
    Pharmacol Biochem Behav; 1982 Oct 15; 17(4):619-22. PubMed ID: 6184731
    [Abstract] [Full Text] [Related]

  • 12. Selective increase of brain dopamine synthesis by sulpiride.
    Tagliamonte A, DeMontis G, Olianas M, Vargiu L, Corsini GU, Gessa GL.
    J Neurochem; 1975 Apr 15; 24(4):707-10. PubMed ID: 1123624
    [No Abstract] [Full Text] [Related]

  • 13. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL, Ailion J, Zwanziger J.
    J Pharmacol Exp Ther; 1968 Nov 15; 164(1):122-34. PubMed ID: 4387046
    [No Abstract] [Full Text] [Related]

  • 14. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
    Waldmeier PC, Maître L.
    Arzneimittelforschung; 1978 Nov 15; 28(9):1507-8. PubMed ID: 582544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism.
    Jacoby JH, Howd RA, Levin MS, Wurtman RJ.
    Neuropharmacology; 1976 Sep 15; 15(9):529-34. PubMed ID: 980228
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.